L'uso della tecnologia nella diabete in gravidanza: una dichiarazione di posizione di opinione esperta dall'Associazione di diabetologi medici (AMD), la Società italiana di diabetologia (SID) e il gruppo di studio interassociativo diabete e gravidanza.

Over the last 10 years, the number of women with diabetes during pregnancy has increased steadily. Maternal glycaemic control is the most important factor influencing maternal and neonatal outcomes, and technological advances have become integral to the evolution of diabetes care during pregnancy. However, rapid technological development must be accompanied by the equally rapid dissemination of information. In particular, knowledge of the availability of automated insulin delivery (AID) systems for managing type 1 diabetes in pregnancy, and of glucose continuous monitoring (CGM) systems for gestational and type 2 diabetes, needs to be increased. The AMD-SID Italian Diabetes and Pregnancy Stu